Sinphar Pharmaceutical Co Ltd
TWSE:1734
Sinphar Pharmaceutical Co Ltd
TWSE:1734
Price:
30.9
TWD
-0.64%
Market Closed
Market Cap:
NT$5.9B
Cash Flow Statement
Cash Flow Statement
Sinphar Pharmaceutical Co Ltd
Sinphar Pharmaceutical Co Ltd
Currency: TWD
| Mar-2022 | Jun-2022 | Sep-2022 | Dec-2022 | Mar-2023 | Jun-2023 | Sep-2023 | Dec-2023 | Mar-2024 | Jun-2024 | Sep-2024 | Dec-2024 | Mar-2025 | Jun-2025 | Sep-2025 | ||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | ||||||||||||||||
| Net Income |
(119)
|
(2)
|
240
|
245
|
273
|
208
|
186
|
306
|
291
|
332
|
314
|
307
|
338
|
340
|
400
|
|
| Depreciation & Amortization |
336
|
270
|
270
|
267
|
260
|
251
|
247
|
244
|
247
|
251
|
256
|
257
|
259
|
258
|
256
|
|
| Other Non-Cash Items |
29
|
24
|
24
|
23
|
25
|
22
|
21
|
(42)
|
(42)
|
(38)
|
(37)
|
22
|
22
|
19
|
21
|
|
| Cash Taxes Paid |
44
|
44
|
51
|
47
|
49
|
58
|
57
|
57
|
58
|
14
|
5
|
5
|
5
|
43
|
42
|
|
| Cash Interest Paid |
31
|
25
|
26
|
28
|
30
|
32
|
33
|
34
|
34
|
35
|
36
|
36
|
36
|
36
|
35
|
|
| Change in Working Capital |
(106)
|
15
|
(177)
|
(110)
|
(205)
|
(120)
|
(150)
|
(210)
|
(74)
|
(141)
|
13
|
7
|
(21)
|
(49)
|
(104)
|
|
| Cash from Operating Activities |
140
N/A
|
308
+119%
|
357
+16%
|
425
+19%
|
353
-17%
|
361
+2%
|
304
-16%
|
296
-3%
|
423
+43%
|
403
-5%
|
546
+35%
|
594
+9%
|
599
+1%
|
569
-5%
|
573
+1%
|
|
| Investing Cash Flow | ||||||||||||||||
| Capital Expenditures |
(198)
|
(159)
|
(161)
|
(153)
|
(163)
|
(210)
|
(272)
|
(301)
|
(355)
|
(341)
|
(291)
|
(257)
|
(187)
|
(174)
|
(182)
|
|
| Other Items |
(42)
|
(31)
|
14
|
29
|
26
|
20
|
(38)
|
(34)
|
(37)
|
(76)
|
(95)
|
(134)
|
(190)
|
(106)
|
(43)
|
|
| Cash from Investing Activities |
(240)
N/A
|
(191)
+21%
|
(147)
+23%
|
(124)
+16%
|
(136)
-10%
|
(190)
-39%
|
(309)
-63%
|
(335)
-8%
|
(392)
-17%
|
(417)
-6%
|
(386)
+8%
|
(391)
-1%
|
(378)
+3%
|
(280)
+26%
|
(225)
+20%
|
|
| Financing Cash Flow | ||||||||||||||||
| Net Issuance of Common Stock |
16
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
0
|
|
| Net Issuance of Debt |
96
|
(199)
|
(179)
|
(219)
|
(497)
|
(352)
|
(12)
|
32
|
182
|
189
|
(131)
|
(42)
|
(122)
|
(253)
|
(143)
|
|
| Cash Paid for Dividends |
0
|
0
|
(34)
|
(34)
|
0
|
0
|
(168)
|
(168)
|
0
|
0
|
0
|
(168)
|
0
|
0
|
(349)
|
|
| Other |
159
|
36
|
(21)
|
(11)
|
(10)
|
(10)
|
(15)
|
15
|
15
|
16
|
31
|
1
|
1
|
(0)
|
(1)
|
|
| Cash from Financing Activities |
238
N/A
|
(196)
N/A
|
(233)
-19%
|
(263)
-13%
|
(541)
-105%
|
(395)
+27%
|
(195)
+51%
|
(121)
+38%
|
29
N/A
|
38
+29%
|
(100)
N/A
|
(209)
-108%
|
(289)
-38%
|
(421)
-46%
|
(493)
-17%
|
|
| Change in Cash | ||||||||||||||||
| Effect of Foreign Exchange Rates |
8
|
7
|
12
|
5
|
(3)
|
(10)
|
(3)
|
(4)
|
(1)
|
13
|
6
|
8
|
10
|
(32)
|
(21)
|
|
| Net Change in Cash |
146
N/A
|
(72)
N/A
|
(11)
+85%
|
43
N/A
|
(327)
N/A
|
(234)
+28%
|
(203)
+13%
|
(163)
+20%
|
59
N/A
|
37
-37%
|
66
+77%
|
1
-98%
|
(58)
N/A
|
(164)
-182%
|
(166)
-1%
|
|
| Free Cash Flow | ||||||||||||||||
| Free Cash Flow |
(58)
N/A
|
148
N/A
|
196
+32%
|
272
+39%
|
190
-30%
|
151
-21%
|
32
-78%
|
(5)
N/A
|
67
N/A
|
62
-8%
|
255
+310%
|
337
+32%
|
412
+22%
|
395
-4%
|
391
-1%
|
|
Switch to:
Switch to:
See Also
Discover More
